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The centrosomal OFD1 protein 
interacts with the translation 
machinery and regulates the 
synthesis of specific targets
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Protein synthesis is traditionally associated with specific cytoplasmic compartments. We now show that 
OFD1, a centrosomal/basal body protein, interacts with components of the Preinitiation complex of 
translation (PIC) and of the eukaryotic Initiation Factor (eIF)4F complex and modulates the translation 
of specific mRNA targets in the kidney. We demonstrate that OFD1 cooperates with the mRNA binding 
protein Bicc1 to functionally control the protein synthesis machinery at the centrosome where also the 
PIC and eIF4F components were shown to localize in mammalian cells. Interestingly, Ofd1 and Bicc1 
are both involved in renal cystogenesis and selected targets were shown to accumulate in two models 
of inherited renal cystic disease. Our results suggest a possible role for the centrosome as a specialized 
station to modulate translation for specific functions of the nearby ciliary structures and may provide 
functional clues for the understanding of renal cystic disease.
The initiation of mRNA translation in eukaryotes is an articulated process composed of different steps. Among 
these, the formation of the Preinitiation complex (PIC) and of the eIF4F complex is finely regulated. Specific 
translation factors contribute to the modulation of initiation by interacting with the ribosome, the mRNA and/
or other translation factors. In particular, the PIC includes the 40S ribosomal subunit and several initiation fac-
tors, like eIF2 and eIF3; then, eIF4E, eIF4A and eIF4G associates with the PIC to form the eIF4F complex and 
promote Cap-dependent translation1–3. Signaling pathways can impact translation at multiple steps. For instance, 
the phosphorylation status of eIF2α and eIF4E availability is rate limiting for translation efficiency4, 5. mTORC1 
(mechanistic Target Of Rapamycin Complex 1) phosphorylates 4E-binding proteins (4E-BPs) and inhibits their 
sequestering activity towards eIF4E, thus upregulating translation6–8.
In eukaryotic cells, a further mean of translation regulation consists in sorting mRNAs to different intracellu-
lar localization. According to their destination in the cells, mRNAs can indeed be sequestered from the ribosome 
machinery9 or have their translation enhanced10. This can be evident at both spatial and temporal levels. For 
instance, analysis of mRNA localization in Drosophila showed their different localization in specific cell com-
partments during embryonic development11. Interestingly, components of the translational machinery, namely 
eIF4E, eIF4A1, and also 4E-BP1, have also been localized to centrosomes12–14. These observations suggest a still 
unexplored link between the translational machinery and the centrosome.
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OFD1 encodes a centrosome/basal body-associated protein15 with a critical role in cilia formation16–18. 
Mutations in OFD1 have been associated with Oral-facial-digital type I (OFDI) syndrome, a pleiotropic disorder 
characterized by renal cystic disease19–21. Other cilia-associated disorders with renal involvement include auto-
somal dominant (ADPKD1 and 2 associated to mutations in PKD1 and 2, respectively) and recessive renal cystic 
disease, Nephronophthisis (NPHP), Bardet-Biedl (BBS), as well as von Hippel-Lindau, Tuberous Sclerosis (TSC) 
syndromes22. Studies also link the RNA-binding protein bicaudal C homolog 1 (Bicc1) to renal cystic disease in 
patients and animal models23.
We now demonstrate that OFD1 interacts with PIC and eIF4F components and modulates Bicc1/eIFs inter-
action to functionally control the protein synthesis machinery in an mTORC1-independent manner. We also 
show in vivo that OFD1 controls the translation of specific mRNA targets in the kidney. Interestingly, both the 
eIFs and the mRNA targets were localized to centrosome. In addition, we demonstrate that OFD1 controls Bicc1 
localization to the centrosome. Our findings suggest novel functions for the centrosome/basal body and provide 
new clues to follow on the molecular mechanisms underlying renal cystic disease.
Results
OFD1 interacts with the Translation machinery. A proteomic approach based on nano-LC-MS/MS 
analyses identified OFD1 putative interactors which included proteins involved in cellular processes such as 
cilia and cytoskeleton assembly, protein folding and degradation, RNA processing, DNA binding and chromatin 
remodeling. Sixteen per cent of the putative interactors corresponded to components of the protein synthesis 
machinery, such as ribosomal proteins and subunits G and B of the eIF3 complex, which is a PIC component 
(Fig. 1a and Supplementary Table S1).
The interaction between endogenous OFD1 and eIF3B, eIF3G, eIF4E and eIF4G was confirmed by 
co-immunoprecipitation (co-IP) experiments (Fig. 1b and e). We then asked whether OFD1 could modu-
late the formation of the PIC and/or of the eIF4F complex. Co-IP experiments demonstrate that eIFs interac-
tions do occur and that the translational machinery is normally formed in the absence of OFD1 (Fig. 1c and 
Supplementary Fig. 2). Further analysis revealed the presence of an eIF4E-binding site (eIF4E-BS) highly con-
served among OFD1 homologous proteins (Fig. 1d) in vertebrates. We mutagenized the eIF4E-BS conserved 
tyrosine-282 (Y) in serine (S), which belongs to the same class of amino acids (Aa) (polar), and in aspartate (D), 
a negatively charged Aa. Co-IP experiments demonstrated that OFD1 directly binds eIF4E, since mutations of 
the eIF4E binding site result in decreased affinity between endogenous OFD1 and the eIF4E constructs. This was 
more evident when Y282 was mutated in D (Fig. 1d). In addition, we silenced eIF4E in HEK293 cells and immu-
noprecipitated OFD1. In this condition, we observed that OFD1 loses its ability to bind other eIFs (Fig. 1e). Taken 
together these results suggest that OFD1 interacts with at least some components of the translational machinery 
and directly binds eIF4E, which in turn mediates PIC/eIF4F/OFD1 interaction.
OFD1 controls Cap-dependent translation. OFD1-silenced and control HEK293 cells were transfected 
with a construct overexpressing the Renilla luciferase under a constitutive (HSV-TK) promoter. Renilla mRNA 
levels were evaluated by Real-Time PCR and were comparable in the two systems (Supplementary Fig. 1a). We 
then measured luciferase activity and calculated the protein/RNA ratio. This ratio was higher in OFD1-silenced 
cells compared to controls, suggesting that OFD1 acts as a negative regulator of translation (Fig. 2a).
It is well established that the formation of the PIC and eIF4F complex drive translation of capped mRNAs1, 2. 
To test whether OFD1 was involved in the regulation of Cap-dependent translation we transfected OFD1-silenced 
and control HEK293 cells with the pRL-HCV-FL bicistronic reporter plasmid24. In this construct the levels of 
Renilla luciferase represent Cap-driven translation efficiency. Firefly luciferase is under HCV-IRES regulation 
and is Cap-independent and therefore was used as a control reporter (Fig. 2b, top panel). This assay allowed us 
to demonstrate that the Renilla/Firefly luciferase ratio was higher in OFD1-silenced cells compared to controls 
(Fig. 2b, left) indicating that OFD1 specifically regulates Cap-dependent translation.
We previously demonstrated the upregulation of phosphorylated S6 ribosomal protein (rpS6), readout of 
mTORC1 activity, in OFD1-depleted models25. To test whether mTOR pathway contributes to the increased 
translation efficiency of Renilla luciferase, we transfected the pRL-HCV-FL reporter plasmid in the presence 
of rapamycin, a negative regulator of mTORC1 and consequently of Cap-dependent translation26. Rapamycin 
treatment resulted, as expected, in decreased levels of phosphorylated rpS6 (indicated in the figures as PS6) in 
both control and OFD1-silenced cells (Supplementary Fig. 1b). Rapamycin treatment resulted in an inhibition of 
~30% of translation in both siOFD1 treated and control cells (Ref. 24 and Supplementary Fig. 1b). The increase 
in the amount of Renilla luciferase in OFD1-silenced cells was only partially reverted by rapamycin treatment 
(Fig. 2b). This suggests an accumulation of the exogenous protein prior the drug administration. We validated the 
effect of OFD1 inactivation on Cap-dependent translation by transfecting the pRL-HCV-FL construct in HeLa 
cells. We show that OFD1 depletion does not result in perturbation of mTORC1-dependent phosphorylation of 
rpS6 (Supplementary Fig. 1c,d). Collectively, these results suggest that the role of OFD1 in protein synthesis is 
mTOR-independent.
We also treated HEK293 cells with cycloheximide (CHX), an inhibitor of translation. After CHX treatment, 
the rate of degradation of Renilla was comparable between OFD1-silenced and control cells, suggesting that nor-
mal protein degradation occurred and that the accumulation of Renilla observed in OFD1-silenced cells was due 
to upregulation of translation (Supplementary Fig. 1e). To confirm the specificity of the siRNA against human 
OFD1 we overexpressed the murine Ofd1, which is not silenced by the siRNA (Supplementary Fig. 2) against the 
human transcript and we obtained an almost complete rescue of luciferase accumulation in OFD1-silenced cells 
(Fig. 2c) thus supporting the role of Ofd1 in translation.
www.nature.com/scientificreports/
3Scientific RepoRts | 7: 1224  | DOI:10.1038/s41598-017-01156-x
OFD1 controls the protein synthesis of specific targets in the kidney. To verify the biological rele-
vance and the physiological significance of our findings, we set up experiments to study the role of Ofd1 in trans-
lation in vivo in a conditional mouse model (Ofd1-IND) in which the Ofd1 gene is inactivated at Postnatal day 
(P)027. Ofd1-IND mice display about 80% Ofd1 inactivation. Renal tubule dilation appeared at P10, while at P18 
the majority of the renal parenchyma was replaced by cysts. Biochemical and immunofluorescence (IF) studies 
revealed increased levels of phosphorylated rpS6 and 4E-BPs, two of the main targets of the mTORC1 pathway 
starting from P10 (Supplementary Fig. 3).
Polysomes represent a complex of ribosomes bound to mRNAs that are being actively translated. These 
mRNAs can be separated from untranslated mRNA by extracting polysomal fractions28. We extracted polysomes 
from HEK293 cells and wild-type (wt) murine kidneys and demonstrated the presence of the OFD1 protein in 
polysomes at P8 and P20 (Fig. 3a and data not shown). We also validated in vivo the interaction between Ofd1 and 
eIF3B in polysomes extracted from wt kidneys (Fig. 3a).
We then analyzed the renal polysomal profile from Ofd1-IND mice (Fig. 3b). The polysomal RNA content 
was quantified in vivo at precystic (P8) and cystic (P20) stages. A significant difference was observed at P20 
(Fig. 3c), correlating with rpS6 phosphorylation at this stage (Supplementary Fig. 3). At P8, when the levels of 
Figure 1. OFD1 interacts with the translational machinery. (a) OFD1 interactome. The putative OFD1 partners 
were clusterized in functional classes, which are identified by a color code. The majority of interactors are 
involved in the control of the cellular protein content (different shades of orange and red). (b) OFD1 interacts 
with components of the PIC and the eIF4F complex. Co-IP experiments performed on total lysates (TL) from 
HEK293 cells. (Upper panels) eIF3B and eIF3G were immunoprecipitated and OFD1 was detected by WB. 
(Lower panels) OFD1 was immunoprecipitated and different subunits of the PIC and of the eIF4F complex 
(eIF3B, eIF3G, eIF4G, eIF4E) were detected by WB. IgG were used as control. Holocytochrome-c type-synthase 
(HCCS) and Citrato synthase (CS) were used as negative controls. All lanes are from the same blot. However 
some of the lanes were not adjacent and are separated by a space. (c) Co-IP experiments demonstrate that 
eIF4E binds other PIC and eIF4F components (eIF3B, eIF4G and S6) in OFD1 silenced cells. Lower panel in 
c reports the effect of OFD1 silencing at the protein level. (d) OFD1 directly binds eIF4E. An eIF4E binding 
site (eIF4E-BS, Aa in red) is recognized in the OFD1 protein and conserved in OFD1 vertebrate homologs. Aa 
mutagenized within the eIF4E-BS are depicted in green. Co-Ip experiments demonstrated that the mutated 
constructs show a lower affinity for eIF4E (right panel). βtubulin was used as loading control. TLs are reported 
on the left. The eIF4E/OFD1 ratio was calculated and the fold change was reported below the panels as the 
mean ± standard error of the mean (SEM). (e) eIF4E mediates the interaction of OFD1 with eIFs. OFD1 was 
immunoprecipitated in control and eIF4E-silenced HEK293 cells and eIF4G, eIF3B and eIF4E were detected by 
WB. IgG were used as loading control.
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phosphorylated rpS6 are comparable between OFD1 depleted models and controls, (Ref. 25 and Supplementary 
Fig. 3), the polysomal profile displayed a similar pattern between Ofd1-IND and controls, indicating that mRNA 
translation, as a whole, is not altered (Fig. 3b,c). We reasoned that OFD1 might regulate the translation of spe-
cific targets in vivo. We then performed microarray analysis on total and polysomal mRNAs from controls and 
Ofd1-IND mutant kidneys. We choosed to perform the experiments at the precystic stage P8 to avoid conditions 
of mTORC1 activation, as marked by rpS6 phosphorylation. We identified 141 targets differentially present in 
polysomal mRNAs (p-value < 0.05) (Supplementary Table S2). Comparing Ofd1-IND to control samples, nine 
targets showed different levels in both total and polysomal RNA. This indicates a bias possibly due to transcrip-
tion and/or mRNA stability, independently from translation efficiency. On these bases, we did not proceed with 
further characterization of those mRNAs. The remaining 132 targets were subjected to bioinformatics analy-
sis (Supplementary Table S3). Gene Ontology of the differentially translated mRNAs did not reveal significant 
enrichment of biological terms or functions. Gene co-expression relationships provide important clues about 
gene function. We thus decided to verify whether the mRNAs were co-expressed and queried the Netview tool29 
with the 132 murine probe sets (127 unique gene symbols) representing the differentially translated targets. Our 
analysis revealed a mouse sub-network containing 78 nodes and hierarchical clustering showed two separate clus-
ters of correlated genes, namely Cluster-1 and -2 (Supplementary Fig. 4A and Supplementary Table S4). Similar 
results were observed by loading the mouse sub-network in Cytoscape30 and by performing the analysis on the 
entire collection of 141 targets (Supplementary Fig. 4B,C). Forty-nine out of the differentially translated tran-
scripts were unrelated to the others. Over 95% of Cluster-1 transcripts were underrepresented in polysomes while 
all transcripts belonging to Cluster-2 were enriched (Supplementary Table S5).
OFD1 targets accumulate in cystic kidneys. Since our in vitro data suggested that OFD1 is a negative 
regulator of translation, we focused on the characterization of the mRNAs enriched in polysomes upon Ofd1 
depletion (Cluster-2). Previous data linked RhoA and the actin cytoskeleton to ciliogenesis31, 32, and renal cysts33 
we thus selected for further validation, among the identified targets, transcripts that encode RhoA-actin associated 
proteins, namely Neuroepithelial-Cell-transforming-1 (Net1), vinculin (Vcl) and GDP-dissociation-inhibitor-2 
(Gdi2). In addition, we selected the Vacuolar-Protein-Sorting-39 homolog (Vps39) as an example of a correlated 
target not associated to cilia biology and the Growth Hormone (Gh) as an unrelated target, not present in any 
cluster. We first performed Real-Time PCR on renal polysomal mRNAs extracted at P8 and P20 and confirmed 
increased translation of the five targets (Fig. 4a). We also measured mRNA total levels and demonstrated that they 
were comparable in Ofd1-IND mutants and controls (Fig. 4b). We then analyzed kidney lysates from Ofd1-IND 
mice and confirmed increased protein levels for all targets analyzed (Fig. 4c). We asked whether the accumula-
tion of the targets is due to translation efficiency and not protein degradation impairment. OFD1-silenced and 
control cells were treated with cycloheximide (CHX), a potent inhibitor of protein synthesis, and with MG132, a 
known proteasome inhibitor. Analysis of NET1, GDI2 and VCL was not informative probably due to the half-life 
of the proteins which is unknown for NET1 and >30 hours for GDI2 and VCL34. Our results indicated that the 
Figure 2. Cap-dependent translation is increased in OFD1-silenced cells. (a) OFD1-silenced cells (siOFD1; 
black bar) and control cells (Control; white bar) were transfected in triplicate with a plasmid overexpressing the 
Renilla luciferase under a constitutive promoter. Luciferase activity and Renilla mRNA levels were calculated 
and the ratio was reported in the graph. (b) On the top a scheme of the pRL-HCV-FL reporter plasmid is 
depicted. OFD1-silenced cells (siOFD1; black bar) and controls (Control; white bar) were transfected in 
triplicate with the reporter plasmid. The Renilla/Firefly luciferase light-unit ratio was calculated; the value for 
control cells was set at 1 and the fold change for all the samples was calculated and reported in the graph (left). 
The same experiment was performed in cells treated with rapamycin (RAPA, black bar) (graph on the right). 
The OFD1-silenced (siOFD1)/control (Control) cells ratio was calculated in untreated (NT, white bar) and 
treated (black bar) cells. (c) The accumulation of Renilla was rescued by overexpressing the murine form of 
Ofd1 (AAV.mOfd1), which is insensitive to siRNA. Data are presented as the mean ± SEM. Student’s t-test or 
wilcoxon test was used to calculate the p value as reported in Methods. **p-value < 0.02; ns: p-value > 0.05.
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accumulation of VPS39 and GH observed in OFD1-silenced cells was recovered only by CHX treatment suggest-
ing that the proteins are normally degraded and that their accumulation is associated with increased synthesis 
(Supplementary Fig. 4d). We also tested two of the targets that were depleted from polysomes upon Ofd1 inacti-
vation, namely ACSL4 and CPT1A. We indeed demonstrated that their protein levels were reduced in Ofd1-IND 
samples (Supplementary Fig. 4e).
We also tested an additional model of inherited renal cystic disease, the Ksp-Cre;Pkd1flox/flox mouse, in which 
the Pkd1 transcript, whose human homolog is mutated in ADPKD1, is conditionally inactivated in renal tubules 
resulting in renal cysts at birth35. Interestingly, we observed protein accumulation for all targets analyzed in kid-
ney lysates from Ksp-Cre;Pkd1flox/flox mutants (Fig. 4e). In this model mRNA levels for Vcl and Net1were increased 
while no significant differences were observed for the other targets (Fig. 4d). These results demonstrated renal 
protein accumulation of all targets analyzed in two different murine models of inherited renal cystic disease.
Bicc1 binds OFD1 target mRNAs. Our results demonstrated that OFD1 is able to regulate the translation 
of specific mRNA targets. We first asked whether OFD1 could directly bind the specific mRNAs and set up an 
Figure 3. OFD1 is present in polysomal fractions and regulates the translation of specific targets in the 
kidney. (a) OFD1 coimmunoprecipitates with eIF3B in vivo in polysomes. We immunoprecipitated the OFD1 
protein in TL (first lane) and in polysomal fractions (P, second lane) both in HEK293 cells (top panel) and 
in wt kidney extracts (P8) (lower panels) and the OFD1 protein was detected by WB. In TL the abundance 
of immunoprecipitated OFD1 probably reflects the localization of the protein in different cell compartments 
compared to the P fraction. Co-IP experiments confirmed that the interaction between OFD1 and eIF3B occurs 
also in vivo in polysomal fractions. eIF3B and rpS6 were immunoprecipitated from P fractions. Bands appeared 
enriched. These markers were used to demonstrate specificity of the P fractions. GAPDH was detected by 
immunoprecipitation in TL from kidneys and was absent in P and was used as a control for specificity. HCCS 
was used as a negative control both for the specificity of polysomal fractions and of the Co-IP. All lanes are from 
the same blot. However some of the lanes were not adjacent and are separated by a space. (b) Polysomal profiles 
observed in kidneys from Ofd1-IND mutants at P8 (upper panels) and P20 (lower panels). The peaks show the 
absorbance (Abs 254 nm) measured in the collected fractions. The polysomal (P) and subpolysomal (SP) areas 
are indicated. The polysomal fractions were obtained from two independent experiments for each sample. 
(c) Analysis of the polysomal profile. The analysis was performed on renal extracts from Ofd1-IND mice 
calculating the ratio between Polysomal RNA (P-RNA) and subpolysomal RNA (SP-RNA) in Controls (white 
bars) and Ofd1-IND mice (black bars). The RNA was obtained from kidneys of Ofd1-IND mutants and Controls 
at P8 (precystic stage) and at P20 (cystic stage). Data are presented as the mean ± SEM. Student’s t-test was used 
to calculate the p-value. **p-value < 0,05 at P20.
www.nature.com/scientificreports/
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mRNA binding experiments. We immunoprecipitated 3XFLAG-OFD1 in a detergent and salt enriched buffer 
to disrupt OFD1/eIFs interactions (Fig. 5a). We then incubated the protein with total mRNA extracted from 
HEK293 wild type cells to avoid possible influences of OFD1 overexpression on transcription. As a control, an 
Figure 4. Accumulation of specific proteins in Ofd1-IND and Ksp-Cre;Pkd1flox/flox mutant kidneys. (a) Real 
Time-PCR on polysomal mRNAs. The enrichment of Net1, Gdi2, Vcl, Vps39 and Gh was validated in kidneys 
of Ofd1-IND mutants (IND; gray bars at P8, black bars at P20) compared to controls (C; white bars) both at 
P8 and P20. (b–d) Transcriptional levels for Net1, Gdi2, Vcl, Vps39 and Gh were measured by Real-Time PCR 
on mRNA extracted from total kidneys of controls (white bars) and Ofd1-IND mice (black bars in b) and Ksp-
Cre;Pkd1flox/flox mutants (black bars in d). WB analysis showed the accumulation of all targets in renal lysates 
from both Ofd1-IND (c) and Ksp-Cre;Pkd1flox/flox mutants (e). For Gdi2 and Vcl (in e) the αtubulin used for 
normalization come from the same blot. Data are presented as the mean ± SEM. Student’s t-test was used to 
calculate the p-value. ns: not significant, p-value > 0.05; *p-value < 0.05; **p-value < 0.05; ***p-value < 0.01.
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analogous experiment was performed by immunoprecipitating eIF4E in non-denaturating buffer to evaluate the 
levels of mRNA bound to the PIC/eIF4F as control. Real-Time PCR analysis on OFD1-bound RNAs revealed that 
the levels of NET1, VCL, GH, GDI2 and VPS39 were lower if compared to the PIC/eIF4F-bound mRNA, indi-
cating that OFD1 alone does not efficiently bind these mRNAs (Fig. 5b). We then hypothesized that an mRNA 
binding protein could be responsible for the enrichment of mRNA targets in conditions of OFD1 depletion. 
Bicc1 is an mRNA transporter protein, that when mutated results in renal cysts development36. We thus looked 
at the presence of Bicc1 in the protein synthesis machinery by co-IP and found that overexpressed Bicc1 binds 
eIFs. Such interactions are stronger in OFD1-silenced cells while OFD1 still associate with eIF3B when Bicc1 is 
Figure 5. OFD1 cooperates with Bicc1 to control the translation of specific mRNAs. (a) Co-IP experiments 
demonstrate that the IP3 buffer destroys OFD1/eIFs interactions, which are preserved using the Co-IP buffer. 
(b) Real-Time PCR of the OFD1-bound mRNA shows that Net1, Vcl, Gh, Gdi2 and Vps39 are not enriched 
after OFD1 IP (black bars) compared to Control (eIF4E-IP white bars). (c) Silencing of Bicc1 results in stronger 
eIF3B/OFD1 affinity. Similar results are observed when OFD1 is silenced and eIF3B/Bicc1 interaction is 
analyzed. (d) Real-Time PCR of the Bicc1-bound mRNA shows that mRNAs target are enriched after Bicc1 IP 
(grey bars) compared to Control (eIF4E-IP white bars). (e) RNA binding experiments are performed in OFD1- 
and Bicc1-silenced cells. In the absence of OFD1 the binding of target mRNAs to eIF4E (black bars) is more 
efficient compared to controls (white bars); while silencing of Bicc1 results in decreased mRNA enrichment 
(grey bars). (f) IF with an antibody against Bicc1 (green) shows that Bicc1 colocalizes with γtubulin (red) at 
the centrosome and that the amount of centrosomal Bicc1 increases in OFD1-silenced cells (white arrows). 
Representative superresolution images are reported and a magnification of the centrosome is shown in the 
dotted white box. IF in Bicc1-silenced cells is reported as control for antibody specificity. Bicc1 localization 
at the centrosome was quantified by ImageJ and reported in a graph on the right. Main fluorescence intensity 
was calculated in the centrosomal area and reported in white for controls (C) and in black for OFD1-silenced 
cells (siOFD1). Data are presented as the mean + SEM. ns p-value > 0.05; *p-value < 0.05; ***p-value < 0.01 
****p-value < 0.005. Representative images were taken at the same contrast and reported. Bar = 5 μm.
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silenced (Fig. 5c). RNA-binding experiments followed by Real-Time PCR analysis demonstrated that NET1, VCL, 
GH, GDI2 and VPS39 are enriched after Bicc1 immunoprecipitation (Fig. 5d). To further validate our findings, 
we silenced OFD1 and Bicc1, immunoprecipitated eIF4E in silenced and control cells in non-denaturating buffer 
and analyzed the target enrichment by Real-Time PCR. OFD1 silencing resulted in enrichment of the majority 
of targets, which are underrepresented after Bicc1 silencing (Fig. 5e). Although we cannot exclude the presence 
of other cofactors, these results indicate that OFD1 and Bicc1 cooperate to modulate mRNA binding to eIF4E.
Bicc1, the translational machinery and specific mRNAs colocalize to the centrosome. We per-
formed immunofluorescence analysis and detected a diffuse cytoplasmic signal with a centrosomal localization 
for endogenous Bicc1 in control HEK293 cells. In OFD1 silenced cells, however, we observed a more abundant 
Bicc1/γtubulin colocalizing signal. To quantify this observation, we measured by ImageJ the intensity of the Bicc1 
signal (green) in a space of 2 μm3 designed around the centrosomes and marked by γtubulin (Fig. 5f). These 
results indicate an enhanced recruitment of Bicc1 to the centrosome in conditions of OFD1 downregulation.
Components of the translational machinery, namely eIF4E and eIF4A1, have been localized to centrosomes 
in non-mammalian systems12–14, 37. IF experiments in HEK293 cells demonstrated that eIF4E, eIF4A1 and eIF4G 
colocalize with γtubulin, a centrosomal marker (Fig. 6). In addition, OFD1 colocalizes at the centrosome with 
eIF3G and B (Fig. 6d,e). IF experiments performed on eIF4E-siRNA-treated cells demonstrated the specificity of 
the centrosomal eIF4E signal, which decreased in silenced cells (Fig. 6b).
We also evaluated the localization of specific mRNA targets. Renal cells were transfected with 
γtubulin-dsRed38 to label the centrosome/basal body. We then performed RNA in situ with locked nucleic acid 
(LNA) probes designed to recognize Vps39, Net1, Gdi2 and Gh revealing a specific signal at the centrosome 
(Fig. 7 and Supplementary Fig. 5 and data not shown). The colocalization signal between Vps39 and γtubulin 
was quantified and this analysis revealed that colocalization occurs in the majority of the cells. In addition, we 
observed that silencing of Ofd1 resulted in an increased number of cells showing Vps39 and γtubulin colocali-
zation (Supplementary Fig. 5). A commercially available scrambled probe and β-actin were used as controls. All 
together, our data suggest that the centrosome could be a new station with a role in protein synthesis.
Figure 6. Translation initiation factors localize at the centrosome in HEK293 cells. (a) Immunofluorescence 
experiments demonstrate that eIF4G and eIF4E colocalize with γ, a centrosomal marker (arrows). (b) Silencing 
of eIF4E results in downregulation of the signal, confirming the specificity of the immunostaining of the eIF4E 
antibody. (c) Single channel IF are presented for each protein analysed, arrowheads indicate the staining that 
suggest the centrosomal localization. (d) Magnification of IF experiments showing colocalization of eIF3B, 
eIF3G, eIF4E, eIF4A1, eIF4G with centrosomal markers (OFD1 or γtubulin). (e) Analysis of centrosomal 
localization of eIF4E and eIF3B by Superresolution microscopy. IF (left panels) and 3D reconstruction (right 
panels) are provided. Bar = 10 μm. For Superresolution images Bar = 2 μm. For all panels n = 3.
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Discussion
Our analysis of the OFD1 interactome revealed intriguing findings about this centrosome/basal-body protein. 
Some of the putative interactors are involved in expected functions such as cilia assembly and cytoskeleton organ-
ization, others in DNA binding and chromatin remodeling, in line with previous observations, demonstrating 
that OFD1 interacts with the TIP60 complex, which is involved in transcription and chromatin remodeling15.
The largest single category of putative interactors (37%) includes proteins linked to biological processes 
involved in the regulation of cellular protein content such as RNA processing, protein synthesis, protein folding 
and degradation. These findings are in line with previous observations linking cilioproteins to regulation of pro-
teasomal activity, centrosome composition and mRNA processing39–41.
These results were functionally validated demonstrating that OFD1 directly binds PIC/eIF4F components 
and that the binding to eIF4E is necessary for PIC/eIF4F-OFD1 interaction. We showed that OFD1 specifically 
controls the translation of Cap-regulated mRNA reporters in human cells, in vitro. We then confirmed Ofd1 to 
have a role in regulating the translation of specific endogenous mRNAs in vivo, in mouse kidney.
Our RNA binding experiments indicate that OFD1 does not directly bind mRNAs. We found that Bicc1, an 
mRNA binding protein described in isolated cilia42, binds a subset of OFD1 mRNA targets. Interestingly, we 
show that OFD1 and Bicc1 modulate the binding of selected targets to eIF4E. This evidence suggests that the two 
proteins cooperate to regulate the translation of specific mRNAs. Bicc1 functions as repressor of protein synthesis 
through microRNA binding and cytoplasmic clustering43, 44. Our data suggest that this protein can also act as a 
positive regulator of protein synthesis. The role of Bicc1 in protein synthesis may differ according to the subcel-
lular localization and the consequent availability of specific interactors/mRNAs. Moreover, we identified specific 
OFD1 translational targets: some of them resulted to be enriched and others depleted in renal polysomes. When 
transfecting an mRNA reporter in HEK293 cells, we found that OFD1 depletion is able to enhance translation 
at a more general level. This result may be explained by the mRNA overexpression, resulting in OFD1 and its 
cofactors exerting their function in translation independently from the specificity for their physiological targets. 
Overall, our results indicate that OFD1 could function both as negative and positive translation regulator. For 
Figure 7. OFD1 target mRNAs localize at the centrosome. (a) Net1, Gdi2, Gh and Vps39 mRNAs (green) 
colocalize with γtubulin (red) at the centrosome in IMCD3 cells (arrows indicate merged signals). βactin and 
scrambled probes (green) were used as controls. Bar = 10 μm. (b) Superresolution images show target mRNAs 
(green) and γtubulin (red) colocalization. Bar = 2 μm. Representative images were taken at the same contrast 
and reported.
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instance, the impairment in the translation of specific mRNAs in presence of OFD1 on polysomes may be due to 
OFD1 sequestering pivotal translation factors. On the other hand, we found OFD1 association with the transla-
tion machinery to be modulated by Bicc1, suggesting that OFD1 interaction with the polysomes can be disrupted 
to increase translation efficiency. On the basis of in vitro and in vivo experiments, we here propose a role for 
OFD1 in regulating the translation of specific mRNAs.
We generated experimental evidence that suggest that OFD1, its target mRNAs and components of the trans-
lation machinery colocalize at the centrosome. Components of the translational machinery have been localized 
to centrosomes in Drosophila and yeast37, 45, although their role has not been fully understood. We now show a 
centrosomal localization of the translation machinery and of specific mRNAs in mammalian cells.
Eukaryotic cells spatially sort specific mRNAs to achieve mRNA translation directly where required in the 
cell11. Several examples of localized translation occurring also near cellular organelles have been described46, 47. 
Interestingly, Bicc1 has a role in controlling the spatial localization of mRNAs43. Our results also show that Bicc1 
is recruited to the centrosome in absence of OFD1. On the basis of these results, we suggest that OFD1 could 
control the access of Bicc1/mRNAs to the translational machinery at the centrosome to functionally control pro-
tein synthesis. We propose that the centrosome/basal body could represent a specialized station to receive signals 
and rapidly modulate already known and yet to be determined specific functions of the nearby ciliary structures. 
Centrosomal translation could represent a mechanism by which cells respond, quickly and locally, to specific 
stimuli, as already described in neurons48. However, the molecular mechanism by which OFD1, Bicc1 and their 
possible cofactors impact translation needs to be fully characterized.
The OFD1 target mRNAs we identified are involved in different biological processes, e.g. cell death, mitochon-
drial biology, mRNA processing and metabolism. Recent data implicated defective metabolism in the pathogen-
esis of ADPKD35.
Interestingly, some of the identified targets (e.g. Vps39, Arf6, Copb2, Gm4024) were associated with 
vesicle-mediated transport. In 2013, Clement and colleagues demonstrated that clathrin-dependent endocytosis 
contributes to signal modulation at the pocket region of primary cilia49.
A subset of targets, namely Net1, Gdi2 and Vcl, points to actin and focal adhesion dynamics which have been 
functionally related to cilia assembly31, 32, 50 and to the development of renal cysts33. Other targets, such as Vps39 
and Gh, belong to gene ontology categories not associated with cilia biology. However, GH secretion has been 
recently associated with the development of simple renal cysts in patients with acromegaly51. We validated accu-
mulation of these five targets in two different mouse models of renal cystic disease (i.e. OFD1 and ADPKD). The 
remaining uncharacterized mRNAs may represent potential targets to be investigated for a putative role in renal 
cyst development.
Although post-transcriptional regulation of mRNA has not been clearly associated with renal cysts, it is 
noteworthy that Bicc1, which when mutated results in renal cystic disease and ciliary defects52, controls the 
stability of Pkd2 mRNA and its translation efficiency53. Future studies will clarify the potential involvement of 
post-transcriptional RNA regulation in renal cyst development.
mTORC1 is a positive regulator of translation8 and experimental data suggest a potential reciprocal relation-
ship between cilia and the mTOR pathway54, 55. Deregulation of the mTOR pathway and ciliary dysfunction are 
often observed in renal cystic disease, although the functional link among mTOR, cilia and cysts is yet to be deter-
mined56. We previously demonstrated in Ofd1 mutants that deregulation of mTORC1 signaling is also evident 
in non-dilated renal tubules where cilia appear to be present, suggesting that the role of OFD1 in ciliogenesis is 
not related to mTORC1 activation25. We now have evidence pointing to OFD1 regulating protein synthesis inde-
pendently from mTORC1. This is clearly shown by a) in vitro modulation of mTORC1; b) the presence of differ-
entially expressed targets in polysomes extracted at P8 when the levels of rpS6 phosphorylation are not increased; 
and c) the finding of 72 transcripts depleted from polysomes. Moreover, the limited number of targets identified 
suggests that in physiological conditions OFD1 controls the translation only of specific mRNAs.
Some of the targets we identified, namely GH and Vps39, activate mTORC157, 58 and their accumulation might 
underlie mTOR activation in OFD1 depleted models (Ref. 25 and Supplementary Fig. 3).
Translation components are localized throughout the cytoplasm. However, we demonstrate that: a) compo-
nents of the translation machinery localize to the centrosome in mammalian cells; b) the centrosomal protein 
OFD1 physically interacts with proteins involved in translation regulation; c) OFD1 cooperates with the mRNA 
binding protein Bicc1, which is also involved in renal cystic disease, to functionally control the translation of 
specific mRNA targets.
To the best of our knowledge, OFD1 is the first example of a centrosomal protein directly involved in the 
regulation of translation. Our results highlight a possible role for centrosomal/basal body proteins in protein 
translation and provide functional clues for a better understanding of renal cystic disease.
Methods
Cell lines and cell treatments. Human Embryonic Kidney (HEK293) and Human cervical carcinoma 
(HeLa) cells were cultured in DMEM 10% fetal bovine serum (FBS). Murine inner medullary collecting duct 
(IMCD3) cells were cultured in DMEM-F12, 10% Fetal Calf Serum for RNA in situ hybridization experiments. 
Human Kidney 2 (HK2) cell were cultured in D-MEM/D-MEM F12 (1:1) 5% FBS supplied with 1% Glutamine 
and ITS (Insuline 5 ug/ml, Transferrine 5 ug/ml and Selenium 5 ng/ml) from SIGMA.
Media were supplemented with 100 Units/ml penicillin, and 100 μg/ml streptomycin. Cells were grown at 
37 °C with 5% CO2.
Cycloheximide (CHX) (C-7698, SIGMA) and MG132 (C221, SIGMA) were used at 100 µM and 30 µM con-
centration, respectively, to treat cells for 6 hours.
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Proteomic studies. Lysis Buffer: 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% Tween 20, 
5 mM MgCl2, 10% glycerol, proteinase inhibitors.
Washing Buffer: 50 mM Tris-HCl pH 7.4, 300 mM NaCl, 1% Triton X-100, 0.1% Tween 20, 5 mM MgCl2, 10% 
glycerol, proteinase inhibitors.
HEK293 cells expressing 3XFLAG-OFD1 and the empty vector used as control were lysate with the Lysis 
Buffer. Total protein extracts were pre-cleared with mouse IgG agarose beads and incubated ON at 4 °C with 
M2 anti-FLAG agarose-conjugated antibody beads (Sigma). Non-retained proteins were then incubated with 
M2 anti-FLAG agarose-conjugated antibody beads (Sigma) overnight at 4 °C. Beads were washed with Washing 
Buffer. Retained protein complexes were eluted with 3XFLAG peptide, precipitated with methanol/chloroform 
and loaded on 10% polyacrylamide SDS-PAGE. Protein bands, stained with Coomassie colloidal blue (Pierce) 
were excised from gel and subjected to proteomic procedure (Supplementary Fig. 6). The control experiment 
obtained by immunoprecipitation of empty vector transfected cells with anti-FLAG agarose beads allowed to rule 
out unspecific retained proteins as described59.
Nanoscale liquid chromatography coupled to tandem mass spectrometry (nanoLC-MS/MS) analyses of pep-
tide mixtures were performed on a CHIP MS Ion Trap XCT Ultra equipped with 1100 HPLC system and chip 
cube (Agilent Technologies, Palo Alto, CA, USA). After loading, the peptide mixture (10 µl in 0.2% formic acid) 
was concentrated and washed at 4 µl/min in the enrichment column (Agilent Technologies chip), with 0.1% for-
mic acid. The sample was fractionated on a C18 reverse-phase capillary column onto the CHIP at a flow rate of 
200 nl/min, with a linear gradient of eluent B (0.2% formic acid in 95% acetonitrile) in A (0.2% formic acid in 2% 
acetonitrile) from 7% to 60% in 50 min. Peptide analysis was performed using data-dependent acquisition of one 
MS scan (mass range from 400 to 2000 m/z) followed by MS/MS scans of the three most abundant ions in each 
MS scan. Raw data from nanoLC-MS/MS analyses were introduced into MASCOT software package version 2.4 
(Matrix Science, Boston, USA) to search the NCBI human non-redundant protein database (NCBInr at www.
matrixscience.com). NanoLC-MS/MS data were searched using a mass tolerance value of 600 ppm for precursor 
ions and 0.6 Da for MS/MS fragments, trypsin as the proteolytic enzyme, missed cleavages maximum value of 1, 
and Cys carbamidomethylation, pyroglutamate (peptide N-terminal Gln) and Met oxidation as fixed and variable 
modifications, respectively. Candidates with at least 2 assigned peptides with an individual MASCOT score > 18 
were considered significant for identification.
Constructs. Constructs overexpressing the OFD1 protein and the HEK293 stable clones used were 
described15. The AAV mOFD1 was obtained cloning the murine Ofd1 cDNA in pAAV2.1 CMV vector. Gerd 
Waltz provided the FLAG-Bicc1 construct (pcDNA6). Mutagenesis of p3XFLAGOFD1 was obtained using 
QuikChangeII kit (Agilent technology 200523). Primers for mutagenesis are displayed in Table S6. The 
pRL-HCV-FL bicistronic reporter plasmid was described24. pRL-TK Vector for Renilla luciferase was from 
Promega (E2241).
Transfections. HeLa and HEK293 cells were transfected using TransIT®-LT1 Transfection Reagent (Mirus) 
according to the manufacturer’s instructions and cells were collected 72 h from transfection both for WB and 
IF. IMCD3 cells were transfected to overexpress γtubulin-dsRed38 with Lipofectamine2000 (Life technologies, 
12566014) for RNA in situ hybridization experiments. As control, cells were treated with the Transfection reagent 
alone.
Antibodies. The anti-OFD1 and anti-Ofd1, were generated against the human full-length OFD1 protein 
(NM_003611) and a portion of the murine Ofd1 homologous protein (NM_177429 Aa 461–884), respectively, 
and were previously described60. All other antibodies used in this study are commercially available and are 
listed below. From Santa Cruz Biotechnology: eIF3G (R-20 sc-16362), eIF3B (H-300 sc-28857), GAPDH (6C5 
sc-32233), GH (sc-10364), VPS39 (D15 sc-104759), NET1 (H-70 sc50392), IgG mouse (sc-2025), IgG rabbit (sc-
2027). From Cell Signaling Technology: eIF4E (9742), eIF4G (2498), phosphorylated rpS6 (Ser240/244, 5364), 
eIF4A1 (2490), phosphorylated 4E-BP1 (Thr37/46, 9459). From Sigma-Aldrich: VCL (clone hVIN-1 V9131), 
γtubulin (clone GTU-88 T6557) and acetylated tubulin (T6793). From Spring Bioscience GDI2 (D4-GDI E2430). 
References for antibodies’ specificity14, 61: for eIF4E and eIF4A162; for eIF3G63, 64; for eIF3B.
Immunoprecipitation (IP). The IP were performed on HEK293 lysates cells at least three times. Buffer 
IP3 (see also Supplementary Fig. 5): 50 mM Tris-HCl pH 8, 150 mM NaCl, 1% Triton X-100, 1% Tween 20, 0.5% 
sodium deoxycholate, 10 mM MgCl2, 10% glycerol, protease inhibitors.
Co-immunoprecipitation (co-IP) experiments and Immunoblot analysis. HEK 293 cells and kid-
neys from fed animals were homogenized in lysis buffer (Tris 50 mM pH 7.9, 1% triton X-100, 0.1% Tween20, 
150 mM NaCl, 10% glycerol, 5 mM MgCl2) or in a specific buffer for Co-IP experiments (50 mM Tris-HCl, 1 mM 
EDTA, 10 mM MgCl2, 5 mM EGTA, 0.5% Triton X-100, pH 7.28). For Co-IP experiments, lysates were incubated 
with specific antibodies and IgG, as control, as described65. Co-IP experiments were performed at least three 
times. Western blot (WB) studies were performed at least in triplicate and representative images were shown. For 
Co-IP experiments the ratio of IP proteins with respect to the input was 1:50. Blots were quantified by ImageJ. The 
control was settled as 1 and the fold change was calculated and reported below the panels as the mean ± standard 
error of the mean (SEM). Animals were perfused with PBS to eliminate blood traces for detection of the GH pro-
tein. Lysates were treated with protease inhibitors from Sigma-Aldrich (P8340) and phosphatase inhibitors from 
Roche (PhosSTOP, 04906837001). Polyvinylidene difluoride (PVDF) membranes were used for Immunoblot 
(Millipore, US, Immobilon-P, IPVH00010) and ECL western blotting reagent (Thermoscientific, 32106) or Femto 
(Thermoscientific, 34095) were used for detection.
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Immunofluorescence (IF). Cells were fixed in methanol or in PFA 4%. Blocking was performed in PBS 
0.2% TritonX-100, 10% FBS. IF experiments were performed at least three times. For analysis of IF data more 
than 100 cells were counted for each experiment. The significance of the results was calculated by Student’s t-test 
and reported as pvalue. In IF experiments, co-localization at the centrosome were considered biological relevant 
when present in >50% of cells.
For the colocalization analysis at the centrosome, we selected the centrosomal area defined by γtubulin signal 
and measured the fluorescence signal intensity of the protein/mRNA of interest. An equal area was selected in 
three different positions in the cell and the average value was calculated and considered as the mean fluorescence 
intensity of the cell. Cells in which the signals were considered to colocalize were characterized by a higher fluo-
rescence signal at the centrosome compared to the mean fluorescence intensity of the cell. Fluorescence intensity 
was calculated by ImageJ.
High-resolution confocal microscopy “LSM 880/Elyra PS-1” Zeiss with superresolution structured illumina-
tion processing was used to obtain high-resolution images.
RNAi. ON-TARGET plus smart pool siRNAs against human OFD1 (L009300000020), eIF4E 
(L00388400001010) and Nontargeting control pool (D00181010) from Darmachon were used at a concentration 
of 100 μM. The transfection reagent was INTERFERIN (409–10, Polyplus) or Lipofectamine RNAimax (1377800, 
Life Technologies). Silenced cells were used for both WB and IF analyses after 72 hours from transfections.
RT-PCR and Real-Time PCR. Total RNA from cells and kidneys was extracted by the RNeasy Mini Kit from 
QIAGEN (74106). The SuperScript®III First-Strand kit by Life technologies (18080–051) was used according to 
the supplier’s protocol. The LightCycler® 480 SYBR Green I Master Mix (04707516001) was used for all samples. 
For quantitative PCR the final concentration of primers was of 0.4 μM on total extracts and 0.8 μM on Polysomal 
extracts and cDNA obtained from RNA binding experiments. The ΔΔCT method was used for statistical analysis 
to determine gene expression levels. Primers that amplify the Gapdh transcript were used as internal reference. 
All experiments contained three technical replicates and were performed at least three times. Primers for RT and 
Real-Time experiments were reported in Supplementary Table S6.
Bicistronic Luciferase assay. For luciferase reporter experiments, HEK293 cells were transfected with 
the pRL-HCV-FL reporter plasmid. Forty-eight hours post-transfection the luciferase activity was measured 
using the Dual-Luciferase Reporter Assay System (Promega) and Glomax96 microplate luminometer (Promega) 
according to manufacturers’ instructions. Rapamycin 100 nM (AY-22989, LC Laboratories) and Cycloheximide 
100 μΜ (C-7698, SIGMA), were used to treat cells for 5 hours. All assays contained three technical replicates and 
were performed at least three times. Normal distribution of values was evaluated with the Shapiro test. To calcu-
late the p-value we used the Student’s t-test for normal distributions and the Wilcoxon test when samples were 
not normally distributed. The standard error of the mean (SEM) was calculated for each experiment as the SEM 
of a simple mean or mean of ratio.
Polysome fractionation and polysomal RNA extraction. Hypotonic buffer: 5 mM Tris-HCl pH 7.5, 
1.5 mM KCl, 2.5 mM MgCl2.
Extraction Buffer: hypotonic buffer, 0.5% triton X-100, 0.5% Na-deoxycholate, 120 U/ml RNAse inhibitors 
[AM2692 from Ambion], 3 mM DTT, 100 μg/ml cycloheximide.
Buffer3: 50 mM Tris-HCl pH 7.8, 240 mM KCl, 10 mM MgCl2, 250 mM sucrose.
Solution D: 4 M Guanidinium thiocyanate, 25 mM Na-Citrate pH 7, 0.5% Sarcosyl, 100 mM 2-MeSH 
Mercaptoethanol).
HEK293 cells: Cells were treated for 10 min with 100 μg/ml cycloheximide (C-7698 from Sigma-Aldrich) and 
washed with Hypotonic Buffer. Cells were lysed in Extraction Buffer and, after quantification, 1 mg/ml of heparin 
was added.
Kidneys: Tissues were lysed in 1 ml of Buffer3 with 5 mM DTT, 100 μg/ml cycloheximide, 2% triton X-100, 
100 U/ml RNAse inhibitors and, after quantification, 1 mg/ml of heparin was added.
Equal amounts of cellular and kidney lysates were layered on 0.5–1.5 M linear sucrose gradient. Absorbance 
at 260 nm was registered in a curve. The area below the curve of subpolysomal (SP) and polysomal (P) fractions 
was calculated using the Adobe Photoshop program and the SP/P ratio was calculated as read-out of general 
translation.
To purify the RNA, we added 1 ml of isopropanol to each fraction and put the mixed fractions at −20 °C 
ON. After 16 hours, the fractions were centrifuged for 30 min at 15000 rpm at 4 °C. Pellets were resuspended in 
SolutionD. Methods for polysome fractionation, polysomal RNA extraction and analysis of polysomal profile 
were described28.
Polysomal fractions from cells and Ofd1 mutant kidneys and controls were obtained from two different con-
trol and mutant animals from different littermates for each set of experiment.
Animal Models. Ofd1fl/+ females16 were crossed with pCAGGCre-ERTM mice as described27. Ksp-Cre;Pkd1flox/flox 
mice were described35. Cre negative Ofd1fl/y and Pkd1flox/flox mice were used as control. All studies were con-
ducted in strict accordance with the institutional guidelines for animal research and approved by the Italian 
Ministry of Health in accordance to the law on animal experimentation. All animal treatments were reviewed and 
approved in advance by the Ethics Committee of the Animal House facility of the Cardarelli Hospital, (Naples, 
Italy) (protocol number: 870/2015-PR; approval date August 24, 2015) and of the San Raffaele Scientific Institute 
(IACUC-548).
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Microarray experiments. For microarray analysis we collected polysomal and total RNA from kidneys 
of Ofd1-IND and WT mice at P8. We used the Affymetrix Mouse 430 A 2.0 array, 3′-IVT array. Microarray data 
were deposited on ArrayExpress_(E-MTAB-2827).
RNA in situ hybridisation. Washing buffer 20xSCC: 175.2 g NaCl + 88.4 g sodium citrate in 1 L DEPC-H2O. 
Denhardt mix: 1 g BSA, 1 g Ficoll 400, 1 g polyvinylpurrolidon in 50 ml DEPC-H2O. Hybridisation mix: 50% for-
mamide, 10% tRNA, 2% 50x Denhardt mix, 50% Dextran and 20% 20xSSC. Slides were washed with PBS, incu-
bated with 0.1 M triethanolamine with 185 μl acetic anhydride for 10 min and washed with 2xSCC for 5 min RT 
followed by a 5 min wash in 2xSCC with formamide at 37 °C. Cells were permeabilised for 2 h at 54 °C with 0.1% 
tween in PBS for 10 min at 37 °C. Slides were washed with PBS at 37 °C and prehybridised with Hybridisation mix. 
Hybridisation with probes (100 nM) was performed at 54 °C for 18–20 h. Slides were washed twice with 2xSCC 
for 10 min at 54 °C, followed by a wash with 1x SCC for 10 min at 54 °C and twice washed with 0.2xSCC for 20 min 
at 37 °C. Slides were blocked with RNAseA at 37 °C. Slides were finally washed with 0.2xSSC for 15 min RT and 
counterstained with DAPI (1:5000 in PBS). Coverslips were mounted in FluoromountG (Cell Lab, Beckman 
Coulter). LNA Probes (EXIQON) are listed in Table S6.
Murine Vps39 has two isoforms (NM_147153 and NM_178851), which differ for 1 exon. The Vps39 LNA 
probe was generated in common region.
RNAseA: 4 ul 10 mg/ml RNAseA, 2 ul 0.5 M EDTA, 100 ul 20XSSC adjusted to 1 ml with DEPC H2O.
Bioinformatic analysis. PUMA (Propagating Uncertainty in Microarray Analysis) package60, 66–68 was used 
for microarray analysis using default settings. PUMA is based on a Bayesian Hierarchical model that accounts 
for measurements uncertainty and multifactorial design. In this test the error due to multiple testing is controlled 
through the priors and hence this control is embedded in the overall procedure.
Netview and cytoscape web-based platforms were used to analyse the putative targets. Netview (netview.
tigem.it) collects co-expression information for human and murine transcripts29. We queried the Netview net-
work with the 132 mouse probesets (127 unique gene symbols, see Input probe sets in Supplementary Table S3) 
and obtained a corresponding mouse sub-network displaying 78 nodes (see mouse subnetwork in Supplementary 
Table S3).
The hierarchical clustering was obtained applying the function hclust (under the R environment, http://
www.r-project.org/) to the adjacency matrix, by selecting binary (jaccard) as distance between genes.
Cytoscape30 is an open source platform for visualizing molecular interaction networks and integrat-
ing with gene expression profiles and other data. Cytoscape visualization was obtained by applying the 
spring edge-weighted (over mutual information -MI- scores) spring embedded layout (www.cytoscape.org) 
(Supplementary Table S3).
Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 (http://david.abcc.ncifcrf.
gov/) was used to perform Gene Ontology enrichment analysis as described69.
RNA binding experiments. The antibody against eIF4E was immobilized with protein A/G –Sepharose 
resin. A Flag – tag resin (Sigma A2220) was used to immunoprecipitate 3XFLAG-OFD1 and 3XFLAG-Bicc1.
Cellular extracts containing approximately 1 mg of silenced (OFD1 or Bicc1) HEK293 transfected as described 
in supplemental information were precleared on beads (20 uL) in 200 uL of RBB for 1 h at 4 °C to remove RNAs 
and proteins that bind the beads in a non-specific fashion. The lysate is then loaded on A/G –Sepharose resin and 
incubated in the appropriate buffer for Ip and Co-Ip, as described above. Any unbound protein is removed by 
washing three times with the respective buffers and three times with an RNA binding buffer (RBB)/0.1% NP-40 
(RBB buffer: 10 mM Tris-HCl pH 7.5, 1.5 mM MgCl2, 150 mM KCl, 2 ug/mL lupeptin, 0.5% (v/v) aprotinin and 
0.2 mM PMSF), followed by two washes with RBB.
The immunoprecipitated proteins were then incubated ON with 30 ug of total RNA extracted from HEK293 
cells in RBB buffer. The complexes were incubated with RBB/0.1% NP-40 with 1 mg/mL heparin for 10 min at 
4 °C (the heparin wash minimizes non-specific RNA-protein interactions). The beads are washed four times in 
RBB/0.1% NP-40 and bound RNA is eluted from the beads by addition of 200 uL of TES buffer (TES: 10 mM 
Tris-HCl pH 7.5, 1 mM EDTA, 1% sodium dodecyl sulfate (SDS)) and boiled for 3 min. The RNA is phenol/
chloroform (1/1) extracted, with 20 ug of glycogen as a carrier. The amount of RNA bound to proteins is analyzed 
using Real Time-PCR.
References
 1. Aitken, C. E. & Lorsch, J. R. A mechanistic overview of translation initiation in eukaryotes. Nat. Struct. Mol. Biol. 19, 568–576, 
doi:10.1038/nsmb.2303 (2012).
 2. Gonatopoulos-Pournatzis, T. & Cowling, V. H. Cap-binding complex (CBC). Biochem. J. 457, 231–242, doi:10.1042/BJ20131214 
(2014).
 3. de Breyne, S., Yu, Y., Pestova, T. V. & Hellen, C. U. Factor requirements for translation initiation on the Simian picornavirus internal 
ribosomal entry site. RNA 14, 367–380, doi:10.1261/rna.696508 (2008).
 4. Pakos-Zebrucka, K. et al. The integrated stress response. EMBO Rep. 17, 1374–1395, doi:10.15252/embr.201642195 (2016).
 5. Pelletier, J., Graff, J., Ruggero, D. & Sonenberg, N. Targeting the eIF4F translation initiation complex: a critical nexus for cancer 
development. Cancer Res. 75, 250–263, doi:10.1158/0008-5472.CAN-14-2789 (2015).
 6. Gingras, A. C. et al. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13, 1422–1437, doi:10.1101/
gad.13.11.1422 (1999).
 7. Hay, N. & Sonenberg, N. Upstream and downstream of mTOR. Genes Dev. 18, 1926–1945, doi:10.1101/gad.1212704 (2004).
 8. Ma, X. M. & Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307–318, 
doi:10.1038/nrm2672 (2009).
 9. Buchan, J. R. mRNP granules. Assembly, function, and connections with disease. RNA Biol. 11, 1019–1030, doi:10.4161/15476286.
2014.972208 (2014).
www.nature.com/scientificreports/
1 4Scientific RepoRts | 7: 1224  | DOI:10.1038/s41598-017-01156-x
 10. Schwarz, D. S. & Blower, M. D. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell. Mol. Life Sci. 
73, 79–94, doi:10.1007/s00018-015-2052-6 (2016).
 11. Lecuyer, E., Yoshida, H. & Krause, H. M. Global implications of mRNA localization pathways in cellular organization. Curr. Opin. 
Cell Biol. 21, 409–415, doi:10.1016/j.ceb.2009.01.027 (2009).
 12. Shang, Z. F. et al. 4E-BP1 participates in maintaining spindle integrity and genomic stability via interacting with PLK1. Cell Cycle 11, 
3463–3471, doi:10.4161/cc.21770 (2012).
 13. Barnard, D. C., Cao, Q. & Richter, J. D. Differential phosphorylation controls Maskin association with eukaryotic translation 
initiation factor 4E and localization on the mitotic apparatus. Mol. Cell. Biol. 25, 7605–7615, doi:10.1128/MCB.25.17.7605-
7615.2005 (2005).
 14. Filippova, N., Yang, X., King, P. & Nabors, L. B. Phosphoregulation of the RNA-binding protein Hu antigen R (HuR) by Cdk5 affects 
centrosome function. J. Biol. Chem. 287, 32277–32287, doi:10.1074/jbc.M112.353912 (2012).
 15. Giorgio, G. et al. Functional Characterization of the OFD1 Protein Reveals a Nuclear Localization and Physical Interaction with 
Subunits of a Chromatin Remodeling Complex. Mol. Biol. Cell 18, 4397–4404, doi:10.1091/mbc.E07-03-0198 (2007).
 16. Ferrante, M. I. et al. Oral-facial-digital type I protein is required for primary cilia formation and left-right axis specification. Nat. 
Genet. 38, 112–117, doi:10.1038/ng1684 (2006).
 17. Singla, V., Romaguera-Ros, M., Garcia-Verdugo, J. M. & Reiter, J. F. Ofd1, a human disease gene, regulates the length and distal 
structure of centrioles. Dev. Cell 18, 410-424, doi:S1534-5807(10)00051-1 (2010).
 18. Bimonte, S. et al. Ofd1 is required in limb bud patterning and endochondral bone development. Dev. Biol. 349, 179–191, 
doi:S0012-1606(10)01098-5 (2011).
 19. Ferrante, M. I. et al. Identification of the gene for oral-facial-digital type I syndrome. Am. J. Hum. Genet. 68, 569–576, 
doi:10.1086/318802 (2001).
 20. Macca, M. & Franco, B. The molecular basis of oral-facial-digital syndrome, type 1. Am. J. Med. Genet. C Semin. Med. Genet. 151C, 
318–325, doi: 10.1002/ajmg.c.30224 (2009).
 21. Saal, S. et al. Renal insufficiency, a frequent complication with age in oral-facial-digital syndrome type I. Clin. Genet. 77, 258-265, 
doi:CGE1290 (2010).
 22. Hildebrandt, F., Benzing, T. & Katsanis, N. Ciliopathies. N. Engl. J. Med. 364, 1533–1543, doi:10.1056/NEJMra1010172 (2011).
 23. Kraus, M. R. et al. Two mutations in human BICC1 resulting in Wnt pathway hyperactivity associated with cystic renal dysplasia. 
Hum. Mutat. 33, 86–90, doi:10.1002/humu.21610 (2012).
 24. Kruger, M. et al. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated 
translation. Mol. Cell. Biol. 21, 8357–8364, doi:10.1128/MCB.21.24.8357-8364.2001 (2001).
 25. Zullo, A. et al. Kidney-specific inactivation of Ofd1 leads to renal cystic disease associated with upregulation of the mTOR pathway. 
Hum. Mol. Genet. 19, 2792–2803, doi:ddq180 (2010).
 26. Sehgal, S. N. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of 
signal transduction and inhibition of cell cycle progression. Clin. Biochem. 31, 335–340, doi:10.1016/S0009-9120(98)00045-9 
(1998).
 27. D’Angelo, A. et al. Ofd1 Controls Dorso-Ventral Patterning and Axoneme Elongation during Embryonic Brain Development. PLoS 
One 7, e52937, doi:10.1371/journal.pone.0052937 (2012).
 28. Espeillac, C. et al. S6 kinase 1 is required for rapamycin-sensitive liver proliferation after mouse hepatectomy. J. Clin. Invest. 121, 
2821–2832, doi:10.1172/JCI44203 (2011).
 29. Belcastro, V. et al. Transcriptional gene network inference from a massive dataset elucidates transcriptome organization and gene 
function. Nucleic Acids Res. 39, 8677–8688, doi:10.1093/nar/gkr593 (2011).
 30. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 
2498–2504, doi:10.1101/gr.1239303 (2003).
 31. Hernandez-Hernandez, V. et al. Bardet-Biedl syndrome proteins control the cilia length through regulation of actin polymerization. 
Hum. Mol. Genet. 22, 3858–3868, doi:10.1093/hmg/ddt241 (2013).
 32. Antoniades, I., Stylianou, P. & Skourides, P. A. Making the connection: ciliary adhesion complexes anchor basal bodies to the actin 
cytoskeleton. Dev. Cell 28, 70–80, doi:10.1016/j.devcel.2013.12.003 (2014).
 33. Dash, S. N. et al. Sept7b is essential for pronephric function and development of left-right asymmetry in zebrafish embryogenesis. J. 
Cell Sci. 127, 1476–1486, doi:10.1242/jcs.138495 (2014).
 34. Sandoval, P. C. et al. Proteome-wide measurement of protein half-lives and translation rates in vasopressin-sensitive collecting duct 
cells. J. Am. Soc. Nephrol. 24, 1793–1805, doi:10.1681/ASN.2013030279 (2013).
 35. Rowe, I. et al. Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat. Med. 19, 488–493, 
doi:10.1038/nm.3092 (2013).
 36. Bouvrette, D. J., Price, S. J. & Bryda, E. C. K homology domains of the mouse polycystic kidney disease-related protein, Bicaudal-C 
(Bicc1), mediate RNA binding in vitro. Nephron Exp. Nephrol. 108, e27–34, doi:10.1159/000112913 (2008).
 37. Chial, H. J., Stemm-Wolf, A. J., McBratney, S. & Winey, M. Yeast Eap1p, an eIF4E-associated protein, has a separate function 
involving genetic stability. Curr. Biol. 10, 1519–1522, doi:10.1016/S0960-9822(00)00829-0 (2000).
 38. Mans, D. A. et al. Mobility of the von Hippel-Lindau tumour suppressor protein is regulated by kinesin-2. Exp. Cell Res. 314, 
1229–1236, doi:10.1016/j.yexcr.2007.12.020 (2008).
 39. Amato, R., Morleo, M., Giaquinto, L., di Bernardo, D. & Franco, B. A system biology approach to dissect the cilia/centrosome 
complex interactome. BMC Genomics 15, 658, doi:10.1186/1471-2164-15-658 (2014).
 40. Liu, Y. P. et al. Ciliopathy proteins regulate paracrine signaling by modulating proteasomal degradation of mediators. J Clin. Invest. 
124, 2059–2070, doi:10.1172/JCI71898 (2014).
 41. Kim, J. H. et al. Genome-wide screen identifies novel machineries required for both ciliogenesis and cell cycle arrest upon serum 
starvation. Biochim. Biophys. Acta 1863, 1307–1318, doi:10.1016/j.bbamcr.2016.03.021 (2016).
 42. Mohieldin, A. M. et al. Protein composition and movements of membrane swellings associated with primary cilia. Cell. Mol. Life Sci. 
72, 2415–2429, doi:10.1007/s00018-015-1838-x (2015).
 43. Rothe, B. et al. Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA. Mol. Cell Biol. 35, 3339–3353, 
doi:10.1128/MCB.00341-15 (2015).
 44. Park, S., Blaser, S., Marchal, M. A., Houston, D. W. & Sheets, M. D. A gradient of maternal Bicaudal-C controls vertebrate 
embryogenesis via translational repression of mRNAs encoding cell fate regulators. Development 143, 864–871, doi:10.1242/
dev.131359 (2016).
 45. Muller, H. et al. Proteomic and functional analysis of the mitotic Drosophila centrosome. EMBO J 29, 3344–3357, 10.1038/
emboj.2010.210, doi:emboj2010210 (2010).
 46. Holt, C. E. & Bullock, S. L. Subcellular mRNA localization in animal cells and why it matters. Science 326, 1212–1216, doi:10.1126/
science.1176488 (2009).
 47. Weis, B. L., Schleiff, E. & Zerges, W. Protein targeting to subcellular organelles via MRNA localization. Biochim. Biophys. Acta 1833, 
260–273, doi:10.1016/j.bbamcr.2012.04.004 (2013).
 48. Si, K. et al. A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in 
aplysia. Cell 115, 893–904, doi:10.1016/S0092-8674(03)01021-3 (2003).
www.nature.com/scientificreports/
1 5Scientific RepoRts | 7: 1224  | DOI:10.1038/s41598-017-01156-x
 49. Clement, C. A. et al. TGF-beta signaling is associated with endocytosis at the pocket region of the primary cilium. Cell Rep. 3, 
1806–1814, doi:10.1016/j.celrep.2013.05.020 (2013).
 50. Kim, J. et al. Functional genomic screen for modulators of ciliogenesis and cilium length. Nature 464, 1048–1051, doi:10.1038/
nature08895 (2010).
 51. Yamamoto, M. et al. Prevalence of Simple Renal Cysts in Acromegaly. Intern. Med. 55, 1685–1690, doi:10.2169/
internalmedicine.55.6560 (2016).
 52. Maisonneuve, C. et al. Bicaudal C, a novel regulator of Dvl signaling abutting RNA-processing bodies, controls cilia orientation and 
leftward flow. Development 136, 3019–3030, doi:10.1242/dev.038174 (2009).
 53. Tran, U. et al. The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity. 
Development 137, 1107–1116, doi:10.1242/dev.046045 (2010).
 54. Boehlke, C. et al. Primary cilia regulate mTORC1 activity and cell size through Lkb1. Nat Cell Biol 12, 1115–1122, doi:ncb2117 
(2010).
 55. Yuan, S. et al. Target-of-rapamycin complex 1 (Torc1) signaling modulates cilia size and function through protein synthesis 
regulation. Proc. Natl. Acad. Sci. USA 109, 2021–2026, doi:10.1073/pnas.1112834109 (2012).
 56. Nagao, S., Kugita, M., Yoshihara, D. & Yamaguchi, T. Animal models for human polycystic kidney disease. Exp. Anim. 61, 477–488, 
doi:10.1538/expanim.61.477 (2012).
 57. Hayashi, A. A. & Proud, C. G. The rapid activation of protein synthesis by growth hormone requires signaling through mTOR. Am. 
J. Physiol. Endocrinol. Metab. 292, E1647–1655, doi:10.1152/ajpendo.00674.2006 (2007).
 58. Valbuena, N., Guan, K. L. & Moreno, S. The Vam6 and Gtr1-Gtr2 pathway activates TORC1 in response to amino acids in fission 
yeast. J. Cell Sci. 125, 1920–1928, doi:10.1242/jcs.094219 (2012).
 59. Zito, E. et al. Sulfatase modifying factor 1 trafficking through the cells: from endoplasmic reticulum to the endoplasmic reticulum. 
EMBO J. 26, 2443–2453, doi:10.1038/sj.emboj.7601695 (2007).
 60. Liu, X., Milo, M., Lawrence, N. D. & Rattray, M. A tractable probabilistic model for Affymetrix probe-level analysis across multiple 
chips. Bioinformatics 21, 3637–3644, doi:10.1093/bioinformatics/bti583 (2005).
 61. Steinhardt, J. J. et al. Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase. Blood 124, 
3758–3767, doi:10.1182/blood-2014-07-589689 (2014).
 62. Hutt, D. M., Roth, D. M., Vignaud, H., Cullin, C. & Bouchecareilh, M. The histone deacetylase inhibitor, Vorinostat, represses 
hypoxia inducible factor 1 alpha expression through translational inhibition. PLoS One 9, e106224, doi:10.1371/journal.
pone.0106224 (2014).
 63. Martineau, Y. et al. Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate 
translation. Mol Cell Biol 28, 6658–6667, doi:10.1128/MCB.00738-08 (2008).
 64. Zhang, L., Pan, X. & Hershey, J. W. Individual overexpression of five subunits of human translation initiation factor eIF3 promotes 
malignant transformation of immortal fibroblast cells. J. Biol. Chem. 282, 5790–5800, doi:10.1074/jbc.M606284200 (2007).
 65. Holz, M. K., Ballif, B. A., Gygi, S. P. & Blenis, J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through 
dynamic protein interchange and ordered phosphorylation events. Cell 123, 569–580, doi:10.1016/j.cell.2005.10.024 (2005).
 66. Liu, X., Milo, M., Lawrence, N. D. & Rattray, M. Probe-level measurement error improves accuracy in detecting differential gene 
expression. Bioinformatics 22, 2107–2113, doi:10.1093/bioinformatics/btl361 (2006).
 67. Rattray, M., Liu, X., Sanguinetti, G., Milo, M. & Lawrence, N. D. Propagating uncertainty in microarray data analysis. Brief 
Bioinform. 7, 37–47, doi:10.1093/bib/bbk003 (2006).
 68. Pearson, R. D. et al. puma: a Bioconductor package for propagating uncertainty in microarray analysis. BMC Bioinformatics 10, 211, 
doi:10.1186/1471-2105-10-211 (2009).
 69. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics 
resources. Nat. Protoc. 4, 44–57, doi:10.1038/nprot.2008.211 (2009).
Acknowledgements
We thank Drs. Banfi, Diez-Roux, Indrieri, Morleo and Toedt for helpful discussion. We thank Dr. John Blenis for 
pRL-HCV-FL and Dr. Gerd Walz for the pcDNA6-Bicc1 construct. We thank the TIGEM Bioinformatics and 
Microscopy Facilities. We thank E Nusco for assistance. This work was supported by MIUR FIRB (RBRN07BMCT 
to PP), the Italian Fondazione Telethon (TGM11CB3 to BF) and the EC 7-Framework-Programme [FP7/2007-
2013], grant agreement 241955 (BF and RHG). D Iaconis was the recipient of an EMBO short-term fellowship.
Author Contributions
Conceived, designed experiments and wrote the paper: D.I., B.F. Performed experiments: D.I., M.M., M.R., C.C., 
P.P., F.C., M.C., R.T., A.V.K. Analysed data: D.I., P.P., M.R., A.B., V.B., R.H.G., E.M.S., S.G., M.P., B.F.
Additional Information
Supplementary information accompanies this paper at doi:10.1038/s41598-017-01156-x
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
